4th Edition of World Congress on Infectious Diseases
June 21-22, 2023 | Rome, Italy
Market Analysis of Infectious Diseases
The global infectious disease diagnostics market is expected to rise at a CAGR of 7.2 percent from USD 28.1 billion in 2021 to USD 39.8 billion in 2026. The global incidence of infectious diseases and the emergence of COVID-19, as well as rising awareness for early disease identification, a shift in focus from centralised laboratories to distributed POC testing, and technical improvements, are driving market expansion. Infectious disease prevalence in both established and developing nations will boost the infectious disease diagnostics market's growth. The rising number of prescriptions for infectious disease diagnostic tests is due to the diagnosis and management of such disorders. During the projection period, these factors, combined with the growing tendency toward preventative care, are projected to increase demand for infectious disease diagnostics.
Ranjan Ramasamy
IDFISH Technology, United States
Stephen Hsu
Augusta University, United States
Alfonso Recordare
Dell'Angelo Hospital, Italy
Brandon Lucke-Wold
Baylor University, United States
Walter Fabricio Silva Martins
Liverpool School of Tropical Medicine, United Kingdom
Jaime David Acosta Espana
University of Jena, Germany
Rickyle Christopher Balea
The University of the Sunshine Coast, AustraliaSubmit your abstract Today
Title : MVA-based virotherapies in the treatment of infectious diseases
Genevieve Inchauspe, ImmunResQ Department, France
Title : Phage therapy in clinical practice: Experience in chronic bone infections
Alfonso Recordare, Dell'Angelo Hospital, Italy
Title : Essential functions of RNA virus genome beyond the storage of protein-coding information
Alfredo Berzal-Herranz, Instituto de Parasitologia y Biomedicina “Lopez-Neyra”, (IPBLN) CSIC, Spain
Title : The rationale of ethanol inhalation for disinfection of the respiratory tract in SARS-CoV-2-positive asymptomatic subjects
Pietro Salvatori, Private Practice, Italy
Title : Rapid, isothermal detection of Zika virus: a potential alternative to RT-PCR
Rickyle Christopher Balea, The University of the Sunshine Coast, Australia
Title : Comparisons of the molnupiravir, sotrovimab, and remdesivir use for COVID-19 patients in a tertiary hospital of Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan